tiprankstipranks
CareDx, Natera selloffs ahead of CAC meetings overdone, says Raymond James
The Fly

CareDx, Natera selloffs ahead of CAC meetings overdone, says Raymond James

Raymond James analyst Andrew Cooper noted that Nordian and Palmetto are hosting joint Contractor Advisory Committee, or CAC, meetings next week for allograft rejection tests and he thinks that ahead of those meetings that fears of changes to the reimbursement landscape are prompting selloffs in CareDx (CDNA) and to a lesser degree Natera (NTRA). However, he thinks the selloff is "putting the cart before the horse" and views the pullback as overdone. Cooper has a Strong Buy rating on CareDx shares and a Market Perform rating on Natera.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on CDNA:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles